At Manningham Medical Centre, you can find all the data about Keystone Biomedical Bucillamine. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Bucillamine, a thiol antioxidant, prevents …

    https://www.pnas.org/doi/10.1073/pnas.132026099
    Lyophilized bucillamine (purity >99.9%) was provided by Keystone Biomedical (Los Angeles). Just before use, it was reconstituted with sterile water, diluted in 0.45% (wt/vol) saline to a concentration of 50 mg/ml, and diluted further in University of Wisconsin (UW) solution.

Keystone Biomedical, Inc. | SBIR.gov

    https://www.sbir.gov/sbc/keystone-biomedical-inc
    bucillamine and radiocontrast- induced nephropathy DESCRIPTION (provided by applicant): It is proposed to test in animal models the potential efficacy of administration …

Bucillamine: A Potent Thiol Donor with Multiple …

    https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1527-3466.2003.tb00107.x
    Bucillamine has potential to attenuate or prevent damage during myocardial infarction, cardiac surgery and organ transplantation. Bucillamine, a cysteine derivative that …

Bucillamine in Treatment of Patients With COVID-19

    https://clinicaltrials.gov/ct2/show/NCT04504734
    Detailed Description: This is a Phase 3, multi-center, randomized, double blind, placebo controlled, clinical study of bucillamine (2 dosage levels) in patients with …

Bucillamine: A Potent Thiol Donor with Multiple Clinical …

    https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1527-3466.2003.tb00107.x?sid=nlm%3Apubmed
    Dr. Horwitz is an officer and major stockholder of Keystone Biomedical Inc., which holds patent rights on certain potential uses of bucillamine that are cited in this …

Bucillamine and Radiocontrast - Induced Nephropathy

    https://grantome.com/grant/NIH/R41-DK072644-01
    It is proposed to test in animal models the potential efficacy of administration of bucillamine a potent antioxidant and immunomodulating agent for prevention o...

Bucillamine, a thiol antioxidant, prevents …

    https://www.pnas.org/doi/pdf/10.1073/pnas.132026099
    Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury Farin Amersi*, Sally K. Nelson†, Xiu Da Shen*, Hirohisa Kato*, Judy Melinek*, Jerzy W. Kupiec …

Bucillamine: A Potent Thiol Donor with Multiple Clinical …

    https://www.researchgate.net/publication/6644985_Bucillamine_A_Potent_Thiol_Donor_with_Multiple_Clinical_Applications
    Bucillamine, a... | Find, read and cite all the research you need on ResearchGate ... Powdered bucillamine (>99% purity) was purchased from Keystone …

BUCILLAMINE AND RADIOCONTRAST - INDUCED …

    https://www.sbir.gov/sbirsearch/detail/209724

Thiol Antioxidants Inhibit the Adjuvant Effects of …

    https://cfpub.epa.gov/ncer_abstracts/index.cfm/fuseaction/display.files/fileID/13999
    2 M.A.H. and L.D.H. are major stockholders in Keystone Biomedical, Inc., which provided the bucillamine for this study. 3 Address correspondence and reprint requests to Dr. …



Need more information about Keystone Biomedical Bucillamine?

At Manningham Medical Centre, we collected data on more than just Keystone Biomedical Bucillamine. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.